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Integration of Pharmacogenomics and Pharmacovigilance in the curricula of future healthcare professionals is 
essential towards individualized medicine and drug safety.  Researchers are lacking in Knowledge, attitude and 
practice regarding pharmacogenovigilance in drug safety among Malaysian future health professionals. This 
study is to develop and validate a reliable questionnaire for evaluation of knowledge, attitude and practice of 
future Doctors and Pharmacists concerning Pharmacogenovigilance in drug safety. A 49-item self-administered 
questionnaire was developed from the literature. The content was validated by a panel of relevant experts 
followed by face validity. A pilot study on 100 respondents was conducted for reliability, followed by a cross-
sectional study involving 247 participants in factor analysis. The content validity index of the whole 
questionnaire was 0.8%. The overall Cronbach‟s Alpha was 0.8, with P<0.001.  67.4% of the total variance was 
explained by 13 factors, and we can conclude that the questionnaire is a valid and reliable instrument.  
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INTRODUCTION 
 
Pharmacogenomics is the study of variability in 
pharmacokinetics and pharmacodynamics in relation to genetic 
variations. If genetic factors are taken into account appropriately 
prior to drug treatment, the regimen can be personalized to the 
individual patient need, hence promote drug safety. Clinicians 
are increasingly anticipated to incorporate pharmacogenomics 
into practices, but this expectation has been below
 
projected. 
Therefore, it is important that future physicians and pharmacists 
are exposed to these important areas.  A measuring tool like 
questionnaire could assist medical educators and health care 
providers in evaluating the teaching programs for future Doctors 
and Pharmacists and necessity of retraining. Previous studies 
revealed an urgent requirement for greater emphasis on   practice  
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and   knowledge   of   pharmacogenomics and pharmacovigilance 
among healthcare professionals (Adamu et al., 2015a; Adamu et 
al., 2015b). Presently, a standardized questionnaire of knowledge, 
attitude, and practice of Medicine and Pharmacy students 
concerning pharmacogenovigilance for drug safety is unavailable. 
Questionnaires that reported either pharmacovigilance or 
pharmacogenomics of Medicine and Pharmacy students are also 
infrequently seen and used on students (Elkalmi et al., 2011; 
Filiptsova et al., 2014). This research would focus on medicine and 
pharmacy students to identify their strength and weaknesses for the 
possibility of providing educational and concrete 
recommendations.  This aimed at developing and reporting the 
psychometric properties of knowledge, attitude, and practice 
(KAP) on Pharmacogenovigilance in Drug Safety Questionnaire in 
final-year Medicine and Pharmacy Students: based on Exploratory 
Factor Analysis. The questionnaire could be used in the assessment 
of awareness, attitude and practice concerning pharmaco-
genovigilance. It can also be used by policy makers, community 
programmers and medical educators for evaluation and or 
recommendations.  
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Item Standardization 
Healthcare professionals must be equipped with the 
required skills in evaluating the quality of reported outcomes in the 
literature and obtained from measurement tools in clinical practice. 
These results are frequently assessed using instruments such as 
scales, education tests, questionnaires, and observer ratings that 
attempt to measure factors such as signs, symptoms, knowledge, 
attitudes, or skills in various settings of medical systems (Cook 
and Beckman, 2006). The validity of an instrument refers to “the 
extent to which evidence and principle support the interpretations 
of test scores entailed by the intended application of tests (Aday 
and Cornelius, 2006). It describes how deeply one can justifiably 
trust the outcomes of a test for a particular purpose as interpreted. 
Many measuring tools measure a physical quantity such as weight, 
height, blood pressure, or BMI. Finding from such tools can be 
interpreted directly. In contrast, findings from assessments of 
patient signs and symptoms, physician knowledge, or student 
attitudes have no intrinsic meaning. Rather, they try to measure a 
particular construct, which is not concrete and physical quantity, 
but a collection of abstract models and central beliefs.  The 
findings from any psychometric evaluation have significance 
(validity) only in the circumstance of the intended construct 
(Kimberlin and Winterstein, 2008). Some sources of evidences 
used to support construct validity include: content, internal 
structure, response process, relations to other variables, and 
consequences (Auewarakul et al., 2005; Beckman et al., 2005). 
These are the only sources of evidence that can be generated to 
support the construct validity of interpretations made from the 
results of measurement by the instrument, but rather they are not a 
subdivision of validity. Multiple sources should be considered in 
generating evidences to support any given inferences, and 
irrespective of the quality and strength of a single source-evidence, 
evidence from other sources must be explored (Cizek et al., 2007; 
Downing, 2003). While generating evidence to support validity, 
emphasis should be placed precisely on two threats to validity: 
construct underrepresentation (inadequate sampling of the content 
domain) and factors if non-random influence on scores (bias) 
(Cook and Beckman, 2006; Downing and Haladyna, 2004). 
 
MATERIALS and METHODS  
 
Study Population 
The study covers four randomly selected Malaysia 
universities, including two public and two private schools. The 
population included a sample of final-year pharmacy and medical 
students who were enrolled full-time at public or private schools 
during the study period with informed consent. In this cross-
sectional observational study, final-year Medicine and Pharmacy 
students because of that they must have taken almost all the 
prerequisite courses for graduation. Registered final-year Medical 
and or Pharmacy students at a Malaysian University at the time of 
the study and interested in participating in the study (with 
informed consent) were included, while for exclusion criteria 
involved final year Medicine or Pharmacy students that 
participated in the pilot study, and or mentally or psychologically 
unstable persons and or those decided not to participate by 
disagreeing in the consent form. The sample size for this factor 
analysis was calculated using the rule of thumb: minimum of 5 
sample per one item (Costello and Osborne, 2005). Our 
questionnaire contains 49 items, hence 49x5= 247. Therefore, this 
study was conducted on 247 participants to find out that if our 
most significant domains (knowledge, attitude, and practice) were 
characterized by this analysis in the same intention which were 
categorized initially. 
 
Designing and Standardizing the Questionnaire 
A 59-item self-administered questionnaire were 
structured for assessing basic knowledge of pharmacogeno-
vigilance; familiarity and awareness about pharmacogeno-
vigilance; roles of pharmacogenovigilance in drug safety; training 
on Pharmacogenomics and Pharmacovigilance towards drug 
safety; understanding of basic Pharmacogenomics, and Pharmaco-
vigilance in drug safety; adverse drug reaction (ADRs); perceive 
pharmacogenomic knowledge and individualized medicine. For 
attitudes; questions were designed on attitude towards perceiving 
benefits; risks involved in Pharmacogenomics; interest on 
pharmacogenovigilance and drug safety; the importance of 
pharmacogenovigilance; ethical concerns towards Pharmaco-
genomics and Pharmacovigilance in drug safety. For practice 
questions, activities such as lectures on genetic variation in 
relation to medicine; asking questions about Pharmaco-genomics, 
Pharmacovigilance and adverse drug reactions; reading and 
discussion about Pharmacogenomics, Pharmacovigilance and 
ADRs; application of pharmacogenovigilance towards drug safety 
were designed. The questionnaire used the Likert scale; yes/no and 
always, monthly, every semester, once in my program or never for 
practice section. Lastly, some demographics (age, gender, 
ethnicity, specialty, University type and nationality were included.  
 
Item Generation 
The initial draft of 59-item self-administered 
questionnaire was developed through search into the available 
literature and frequently ask questions (FAQs) (Adam et al., 
2015a; Benzeroual et al., 2012; Filiptsova et al., 2015; Formea et 
al., 2013; Stanek et al., 2013; Taber and Press, 2014). An expert 
panel was formed in order to design flowchart and for 
characterizing the primary domains of our KAP survey. Then, we 
detailed our primary areas to some questions. Experts in the field 
of Public Health (Biostatistician; specifically specialize in 
designing the questionnaire), Associate Professor and consultant 
psychiatrist, Professor of Pharmacology, a Professor of clinical 
Pharmacology, a pharmacogenomic expert, an Associate Professor 
of Pharmacy practice and an Associate Professor of pharmacology 
and ethnopharmacology were the composition of our expert panel.  
 
Item Modification 
Comments and observations from experts working in the 
area of Epidemiology, Biostatistics, Pharmacovigilance and 
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Pharmacogenomics studies were sought during 3
rd
 questionnaire 
development and validation workshop held 25-28
th
 August, 2014 
at the unit of Biostatistics and research methodology, Universiti 
Sains Malaysia.  According to the experts‟ objective opinions, the 
wording, content and the structure of some questions had been 
modified. 
 
Item Reduction (Factor Analysis) 
Factor analysis provides an enhanced understanding of 
which variables form a “relatively coherent subset, independent of 
others” (Cook and Beckham 2006; Fafrigar et al., 1999). This 
study was conducted on 247 participants to find out that if our 
most significant domains KAP were characterized by this analysis 
in the same intention which were categorized initially. The study 
design was cross-sectional, which was intended to reduce the items 
into their appropriate domains. The questionnaire was distributed 
face to face to the study participants by the principal author.    
 
Reliability 
Measurement reliability means reproducibility, 
repeatability, consistency or precision of the instrument (Fletcher 
et al., 1996; Gordis, 2009; Trochim and Donnelly, 2006). A pilot 
study on 100 respondents was conducted for the purpose of 
reliability determination. The sample size was calculated by 
statstodo-software http://www.statstodo.com/SSiz1AlphaPgm.php. 
The questionnaire was distributed face to face to the study 
participant with an informed written consent. At the end of 2 
weeks period, 60 % of the participants responded. There were 2 
incomplete questionnaire and were subsequently removed out of 
the valid responses. A reliability coefficient value of 0 represents 
no correlation (all error), whereas the value of 1 represents the 
absolute relationship between items (all variances attributable to 
subjects). Acceptable limit usually varies according to the intended 
use of the measuring tool. For high-stakes settings (e.g., licensure 
examination) the acceptable reliability value should be greater than 
0.9 whereas for less critical conditions values of 0.8 or 0.7 are 
usually acceptable (Cook and Beckman, 2006).  
 
Face Validity 
It is usually used to describe the form of validity in the 
absence of first-hand testing. The concepts of content evidence and 
face validity are apparently similar but are in fact quite different. 
Whereas content validity entails a systematic professional and 
documented approach to ensure that the instrument measures the 
intended construct accurately, face validity involves judgment on 
the appearance and understanding of each item of the instrument. 
Of significance concerns also are imperfection of assessments 
based on appearance, heterogeneous perceptions between 
developers and users, and in some cases counterproductive 
judgments from appearance might occur (Kimberlin and 
Winterstein, 2008; Montazeri et al., 2005). This study a separate 
sample of 20 participants that fulfilled the inclusion criteria were 
asked to objectively and constructively assess the degree of clarity       
. 
(whether there were ambiguities or multiple ways to interpret the 
question) and comprehension (whether words and sentences of the 
constructed items can be understood easily by respondents) of 
each element to measure domains. The rating was done using a 5-
point Likert scale from 1 = the sentence is very vague, 2= the 
sentence is vague, 3 = the sentence is acceptably clear, 4 = the 
sentence is clear, 5= the sentence is very clear for degree of clarity 
and 1 = the sentence is tough to be understood, 2 = the sentence is 
hard to be understood, 3 = the sentence is acceptable to be 
understood, 4 = the sentence is easy to be understood, 5 = sentence 
is very easy to be understood for the degree of comprehension. 
The face validity index (FVI) for Knowledge, attitude and practice 
were calculated followed by calculation of the content validity 
index of the whole KAP questionnaire. 
 
Content Validity 
The validity of an instrument measuring non-concrete 
concept (construct), in which there is no criterion or directly 
observable phenomenon of the notion Cronbach and Meehl 1955. 
It evaluates the “relationship between a test‟s content and the 
domain it is intended to measure (Aday and Cornelius, 2006). The 
content should symbolize the truth (domain), the whole truth 
(domain), and nothing but the truth (domain). Therefore, we 
consider the concept definition, the intended purpose of the 
instrument, the process for identifying, developing and selecting 
items, the wording of individual items in our questionnaire, and 
the background, qualifications and experience of item writers, 
evaluators and reviewers. The content validity of the final 
questionnaire was determined by the settings panel of 7 experts in 
the field of Public Health (Biostatistician; specifically specialize in 
designing the questionnaire), Associate Professor and consultant 
psychiatrist, Professor of Pharmacology, a Professor of clinical 
Pharmacology, a pharmacogenomic expert, an Associate Professor 
of Pharmacy practice and an Associate Professor of pharmacology 
and ethnopharmacology. Each expert was asked to objectively and 
constructively judge the degree of relevancy (the extent to which 
each item relates to the aspect of the domain/subscale) using rating 
scale 1 = the issue is very irrelevant to the measured domain, 2 = 
item is irrelevant to the measured domain, 3 = the item is 
acceptable relevant to the measured domain, 4 = the item is 
relevant to the measured domain, 5 = the item is very relevant to 
the measure domain and degree of representativeness (how 
completely the item covers the associated aspect of the domain)  
using rating scale 1 = the item is totally not representing the 
domain, 2 = the item is minimally representing the domain 3 = the 
item is satisfactory representing the domain, 4 = adequately 
representing the domain, 5 = the item is accurately representing 
the domain for each question of the questionnaire. They examined 
each statement for omissions and or inappropriate choice of items. 
A qualitative response, guidance was provided for some items so 
that the evaluators would know how some specific questions 
should be answered. The content validity index for Knowledge, 
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attitude and practice were calculated following by calculation of 
the content validity index of the whole KAP questionnaire.  
 
Data Analysis 
The data were explored for wrong entry, missing value. 
Internal consistency of the questionnaire using reliability statistics 
of Cronbach‟s Alpha coefficient was calculated using IBM*SPSS 
20.0 for windows.  Factor analysis (Exploratory factor analysis) 
was employed for data reduction and tailoring the related items 
into theoretically similar and statistically related domains. 
Principal Component Analysis was used for extraction and 
Varimax with Kaiser Normalization (orth.) rotation to get 
maximum variance explained (Hair et al., 2009). A number of 
factors were extracted based on several factors, i.e., Eigenvalue 
larger than 1, Scree plot & factor loading (Fabrigar et al., 1999; 
Ledesma et al., 2007).  Kaiser-Meyer-Olkin (KMO)  measure of 
sampling adequacy and Bartlett‟s test of the sphericity value of 
greater than 0.7 and less than 0.005 were used, respectively, and 
factor loading of 0.3 was considered as cut off point. Demographic 
variables were presented as frequency and percentage using 
descriptive statistics. The differences and correlations were being 
considered statistically significant at P<0.05. The Content Validity 
Index (CVI) and face validity index (FVI) were calculated using 
giving formulae.  
Ethical Approval: The study has been reviewed by the 
Universiti Sultan Zainal Abidin (UniSZA) and UHREC (UniSZA 
Human Research Ethics Committee) and granted approval with 
reference number: UniSZA.N /1/628- (69) dated 21
st
 July, 2014 
(23
rd
 Ramadhan 1435H) before commencement of the research. 
Permission to approach the students was officially obtained from 
the Deans of their respective faculties. All Participants were 
briefed on the research, and they have all signed an informed 
written consent before participating in the study.  
 
RESULTS  
 
The developed questionnaire was 6 pages in length and 
consisted of 60 items classified into the following areas. The first 
part consisted of 11 items, which covering demographic 
characteristics of the respondents such as gender, age, discipline, 
ethnicity, type of university and Nationality. The second part 
consisted of 49 items exploring the knowledge, attitudes and 
practice regarding Pharmacogenomics and pharmacovigilance in 
drug safety.  After the analysis, final extracted items consisted of 
42 questions. The first 17 items were constructed as a series of 
yes/no statements, and the participants were asked to indicate their 
response accordingly. The next 15 items were constructed in forms 
of statement asking the respondents to indicate their agreement or 
disagreement using a 5-point Likert scale format (5 = „„strongly 
agree,‟‟ 4 = „„agree,‟‟ 3 = „„neutral,‟‟ 2 = „„disagree,‟‟ and 1 = 
„„strongly disagree‟‟). The rest of the questions (10 items) also 
used a 5-point Likert scale. The classification of these items in a 
particular domain was not disclosed to the participant before 
distributing the questionnaire to them. 
Demographic Characteristics of Study Participants  
Within four-month study period, a response rate of 
68.4% was recorded, and there was no incomplete response from 
the respondents. Age, date of birth, gender, marital status, religion, 
ethnicity, nationality, discipline and University type of the 
respondents were collected demographic variables. The majority 
of the participants were medical students, and female students 
accounting for 63.3% and 69.85 respectively, with a significant 
difference between the professions. The mean age of the 
respondents was 22.98±1.03 years old, with pharmacy students 
(22.03±0.44) younger than the medical students (23.53±0.85). The 
majority (52.7%) of the respondents were Malay, followed by 
Chinese (37.9%), then Indians (7.7%), Bumiputra (1.2%) and 
others (0.6%).  
 
Psychometric Properties 
 
Face Validity 
The calculated face validity index (FVI) results from 10 
final year Medicine students, and 10 final year Pharmacy students 
were presented in Table 1. And it shows that the face validity 
index-clarity (FVI-Clarity) is 0.80, face validity index- 
comprehension (FVI-comprehension) is 0.87 and total face 
validity index (FVI) is 0.835. Therefore, all values fall above 0.5 
cutoff point. 
 
 Table 1: Face and Content Validity Index of KAP questionnaire. 
S/N  Variables Value 
1 Content Validity Index (CVI)  0.819 
  C VI-relevancy 0.820 
  CVI-Representativeness 0.818 
  Total  0.819 
2 Content Validity Index (FVI)  0.835 
  FVI-Comprehension 0.870 
  FVI-Clarity 0.800 
  Total 0.835 
 
 
Content Validity 
From our findings, the content validity index-relevancy 
(CVI-relevancy) is 0.820, content validity index- 
representativeness (CVI – representativeness) is 0.818 and total 
Content validity index (CVI) is 0.819 as shown in Table 1., 
therefore, the results of Content validity index (CVI) from seven 
experts were greater than 0.5 and were considered as acceptable 
and meritorious 
 
Internal consistency (Reliability) 
For reliability, uniformity and precision, Cronbach‟s 
Alpha scores >0.7, Corrected Item-total correlation >0.5 and the 
values of Cronbach‟s Alpha if item deleted were considered and 
checked for each construct as extracted from EFA. Selected useful 
items by construct were involved in the analysis as shown in Table 
2, 3 and Table 4. 
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Exploratory Factor Analysis (EFA) 
Exploratory factor analysis was performed by 
administering 49-items questionnaire to 247 subjects. From 
correlation matrix the r > 0.3 and p-value < 0.05 were considered 
as cutoff points. Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was 0.804 which is meritorious and was considered 
adequate for the factor analysis. The significant Bartlett‟s test of 
sphericity p-value < 0.001 indicates that there are worthwhile 
correlations     among   the   items,   there  fore,   fit   for   structure  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
elucidation. The commonalities (extraction) values are all above  
0.5 (Practically communality> 0.25), considering factor loading 
>0.5 is acceptable in Communalities (extraction) for Convergent 
validity, thus variance= square of factor loading 0.5
2 
= 0.25. 
Factors were extracted using Principal Component Analysis and 
Varimax with Kaiser Normalization (orth.) rotation. Finally, three 
factors were extracted based on several considerations, i.e., 
Eigenvalue, Scree plot (Figure 1.)  and factor loadings (Fabrigar et 
al., 1999; Ledesma et al., 2007) as shown in Table 2, 3 and 4. 
 
Table 2:  Results of Exploratory Factor Analysis (EFA)-Factor 1. 
Factor Item 
Factor 
Loading 
Corrected 
item 
Total 
correlation 
Cronbach’s 
alpha 
If item 
deleted 
Cronbach’s 
alpha 
   Q1. All medicines in the market are safe.  0.455 0.324 0.777  
   Q2. All traditional medicines are safe because they are natural products  0.463 0.279 0.780  
   Q4. ADR  is any response to medicines that is unintended and occurs at normal doses 
used in humans  
0.371 0.317 0.778  
   Q5. Cytochrome P450 (CYP450) is a drug metabolizing enzyme which has been
affected by genetic variations  
0.410 0.393 0.772  
   Q6. Pharmacovigilance is about drug safety  0.451 0.382 0.773  
   Q7. Public awareness on drug safety information is part of Pharmacovigilance  0.503 0.493 0.763  
   Q8. Genetic variation is a risk factor to adverse drug reaction.  0.597 0.470 0.766  
Knowledge  Q9. Pharmacogenetics is the study of drugs responses in relation to human genetics 
variations.  
0.776 0.579 0.761 0.784 
   Q10. Pharmacogenetics aims at understanding the roles of human genetic variations in 
drugs safety.  
0.704 0.505 0.762  
   Q11. Drug responses to genetic variations influence Pharmacovigilance.  0.639 0.400 0.772  
   Q12. Genetic variations in drug metabolizing enzymes affect drug therapy  0.568 0.424 0.769  
   Q14. The anticoagulant effects of warfarin have been known to be affected by genetic 
variations.  
0.387 0.523 0.764  
   Q15. Genetic variations affect Pharmacological action of some NSAIDs  0.282 0.331 0.777  
   Q17. Genetic variations influence the pharmacological effects of Carbamazepine  0.291 0.326 0.778  
   Q18. Genetics information is now a requirement for some drug labels, according to 
Food and Drug Administration (FDA).  
0.395 0.291 0.781  
   Q19. Based on the drug metabolizing enzymes activity, people can be classified into:  
a. poor metabolizers,               b. slow metabolizers C.  ultra-rapid metabolizers,    d. all 
of the above  
0.302 0.175 0.791  
 
Table  3: Results of Exploratory Factor Analysis (EFA)-Factor 2 
Factor Item 
Factor 
Loading 
Corrected 
item 
Total 
Correlation 
Cronbach’s 
Alpha 
If item 
Deleted 
Cronbach’s 
Alpha 
   Q16.  Reading information about Adverse drug reactions is very difficult  0.306  0.399  0.830     
   Q20. Genetic tests are now available in Malaysia  0.338  0.509  0.823     
   Q21. Genetic tests could be ready in the laboratory within 48hours  0.350  0.556  0.820     
   Q25. I believe that ADRs is a problem that deserves attention  0.425  0.646  0.815     
   Q26. I believe that pharmacovigilance is my professional obligation  0.532  0.480  0.825     
   Q28. I would agree to do genetic test in order to determine the initial dose of related drug 
if I were patient  
0.640  0.628  0.814     
Attitude  Q29. I believe that pharmacovigilance plays essential roles in preventing drug related 
problems  
0.703  0.402  0.832  0.836  
   Q32.I am interested in discovering any information about ADR  0.584  0.689  0.810     
   Q34. I believe that individualized medicines is the best solution to drug-related problems  0.720  0.341  0.836     
   Q35. I believe that individualized medicine can only be possible with the knowledge of 
pharmacogenomics  
0.569  0.650  0.814     
   Q37. I think Pharmacogenetics plays essential role in reducing incidences of adverse drug 
reactions  
0.782  0.372  0.833     
   Q38. I am comfortable reading genetic information in relation to drugs  0.378  0.292  0.835     
   Q39. I believe that Pharmacovigilance and Pharmacogenomics should be linked together 
for better drug safety  
0.686  0.354  0.833     
   Q40. I believe legal issue retards application of genetic information into clinical practice  0.477  0.304  0.835     
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DISCUSSION  
 
The questionnaire was designed to be a self-administered 
questionnaire, and it could also be completed through an in-person 
interview, computerized administration, online or by telephone 
after some modification and validation studies.  It shows that the 
face validity index-clarity (FVI-Clarity) of 0.80, face validity 
index- comprehension (FVI-comprehension) was 0.87 and total 
face validity index (FVI) of 0.835 all values fall above 0.5 cutoff 
point, hence acceptable. The results of Content validity index 
(CVI) from seven experts were all greater than 0.5 and were 
considered acceptable and meritorious.  Based on KMO >0.70 the 
items share common factors and it is a worthy and adequate 
sample. Moreover, a significant Bartlet‟s test of Sphericity 
indicates that there are worthwhile correlations among our items 
based on the correlation matrix. For practical purpose, we                
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
considered >0.25 cut-off point, considering factor loading >0.5 is 
acceptable in Communalities (extraction) for Convergent validity, 
Variance is equal to square of factor loading (Hair et al., 2009). 
Three factors were extracted based on several considerations, i.e., 
Eigenvalue, Scree plot & factor loading (Fabrigar et al., 1999; 
Ledesma et al., 2007). The extraction method used was „‟Principal 
Component Analysis‟‟ and Varimax with Kaiser Normalization 
(orthogonal) rotation to get a maximum variance explained (Hair 
et al., 2006). In general, all the results from psychometric tests of 
the questionnaire showed satisfactory values. Reliability of the 
questionnaire as measured by the Cronbach‟s Alpha coefficient for 
each three scales and for whole at once exceeded the 
recommended value of 0.5. 
This finding is similar to other findings with CVI and 
CVI far higher than 80% which were recommended minimum 
acceptable limit for a new tool (Boggess et al., 2011; Ghasemi et 
Table  4: Results of Exploratory Factor Analysis (EFA)-Factor 3 
Factor Item 
Factor 
Loading 
Corrected 
item 
Total 
Correlation 
Cronbach’s 
Alpha 
If item 
Deleted 
Cronbach’s 
Alpha 
  Q41.Iattempted  drug related case study questions  0.718 0.701 0.884   
  Q42. I ask information about  ADRs 0.482 0.492 0.897   
  Q43. I related genetic variation to ADRs 0.727 0.700 0.884   
  Q44. I discuss about ADRs with friends etc.. 0.514 0.530 0.895   
Practice Q45. I attended lectures that is association with effects of genetics variations on drug 
therapy 
0.700 0.693 0.884 0.897 
  Q46.   I was trained on how to identify ADRs in     pharmacovigilance during my program 0.783 0.701 0.883   
  Q47. I was trained on how to report ADRs in pharmacovigilance 0.778 0.676 0.885   
  Q48. I have had a formal training on pharmacovigilance program 0.751 0.663 0.886   
  Q49.  I employed the idea of human genetic variation when trying to solve  drug-related 
case study questions 
0.771 0.671 0.886   
  Q50. I update my knowledge on genetic information in relation to drugs 0.696 0.628  0.889   
 
 
 
Fig.  1: Scree Plot for factor Analysis 
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al., 2012; Martiniuk et al., 2007; McEvoy et al., 2010; Salcedo-
Rocha et al., 2011). We have not seen published data on the 
validity and reliability from similar questionnaires which we could 
compare our findings. Therefore, we have compared our results 
with standard indices like 0.7 for Cronbach‟s Alpha and 80% for 
CVI. Notwithstanding, this finding is similar to other KAP studies 
(Ghasemi et al., 2012; Grant and Davis, 1997; Johnston et al., 
2003; Rosebraugh et al., 2003; Sirajudeen et al., 2012). 
The results of factor analysis revealed a strong cluster 
structure, suggesting that the questionnaire meets the intended 
domains and could be interpreted as a one-dimensional element by 
the summation of all items. Table 2, 3 and 4 shows that the 
satisfactory values have indicated that the extracted components 
represent the intended domains well, and there was no need to 
extract another component. A factor loading cutoff of > 0.30 was 
adopted. Each factor explained 2.91 to 7.98% of the total variance, 
and 67.45% of the total variance was explained by these 11 
factors, revealing a fair factor structure. Hence, the questionnaire 
should be interpreted as the sum of all items. According to results 
from factor analysis, the extracted factors confirmed that there are 
sufficient numbers of questions in each subdomain that explained 
most of the important aspects of intended to be measured by this 
questionnaire. This study involved both public and private 
Universities, different gender and location. Final-year Medicine 
and Pharmacy students were involved because we believe that they 
must have taken almost all the prerequisite courses for graduation 
from school to start practice under supervision. Therefore, the 
questionnaire for this study could reliably be used for measuring 
KAP concerning pharmacogenovigilance in drug safety amongst a 
broad spectrum of a future healthcare professional in Malaysia. 
 
CONCLUSION 
 
The results from this study revealed that the 
questionnaire assumed acceptable for cluster structures. Therefore, 
it should be interpreted as a one-dimensional element by the 
summation of all items. The questionnaire is a valid and reliable 
measure of final-year Medicine and Pharmacy students‟ KAP 
status concerning pharmacogenovigilance in drug safety in 
Malaysia.  
 
ACKNOWLEDGEMENT 
 
Our special appreciation goes to Engr. Dr. Rabiu Musa 
Kwankwaso, the Executive Governor of Kano State, Nigeria, for 
sponsoring my study in the form of scholarship.  Moreover, we 
thank the management of UniSZA for providing an enabling 
environment for our research. The last, not the least sincere 
appreciation goes to all the participants. 
 
REFERENCES 
 
Adamu Y, Aziz ABA, Haque M. Knowledge, Attitude and 
Practice Concerning Pharmacogenomics among Pharmacists A Systematic 
Review.  J Young Pharm, 2015a; 7: 145–154. 
Adamu Y, Husain RB, Haque M.  A Systematic Review of 
Knowledge, Attitude and Practice towards Pharmacogenomics among 
Doctors. Int J Pharm Res, 2015b; 7: 9–16. 
Aday LA, Cornelius LJ. Designing and conducting health 
surveys: A comprehensive guide, Distribution. John Wiley and Sons. 
2006; 2: 287-309 
Auewarakul  C,  Downing  SM,  Jaturatamrong  U,  
Praditsuwan  R.  Sources of validity evidence for an internal medicine 
student evaluation system: An evaluative study of assessment methods. 
Med Educ, 2005; 39: 276–283. 
Beckman  TJ, Cook  DA, Mandreka  JN.  What is the validity 
evidence for assessments of clinical teaching?  J Gen Intern Med,  2005; 
20: 1159–1164. 
Benzeroual KE, Shah B, Shinde S. Pharmacogenomics: 
Assessing educational exposure, confidence in knowledge and training 
elements of pharmacists. Per Med, 2012; 9: 387-393. 
Boggess KA, Urlaub DM, Moos M-K, Polinkovsky M, El-
Khorazaty  J, Lorenz C.  Knowledge and beliefs regarding oral health 
among pregnant women. J Am Dent Assoc, 2011; 142: 1275–1282. 
Chung W-H,  Hung S-I,  Hong H-S, Hsih M-S, Yang L-C, Ho 
H-C, Wu J-Y, Chen Y-T.  Medical genetics: a marker for Stevens-Johnson 
syndrome. Nature, 2004; 428: 486. 
Cizek GJ, Rosenberg SL, Koons HH.  Sources of Validity 
Evidence for Educational and Psychological Tests. Educ Psychol Meas, 
2007; 68: 397- 412. 
Cook  DA,  Beckman TJ.  Current concepts in validity and 
reliability for psychometric instruments: Theory and application. Am J 
Med, 2006; 119: 166.e7–166.e16. 
Costello AB, Osborne JW. Best practices in exploratory factor 
analysis: Four recommendations for getting the most from your analysis. 
Pract Assessment Res. 2005; Eval, 10: 1–9. 
Cronbach L,  Meehl  P.  Construct validity in psychological 
tests. Psychol Bull, 1955;129: 3–9. 
Downing  SM.  Validity: On the meaningful interpretation of 
assessment data. Med Educ, 2003; 37: 830-837 
Downing SM, Haladyna TM. Validity threats: Overcoming 
interference with proposed interpretations of assessment data. Med Educ, 
2004; 38: 327–333 
Elkalmi RM, Hassali MA, Ibrahim MIM, Widodo RT,  Efan 
QMA, Hadi MA.  Pharmacy students‟ knowledge and perceptions about 
pharmacovigilance in Malaysian public universities. Am J. Pharm Educ, 
2011; 75: 96. 
Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJJ.  
Evaluating the use of exploratory factor analysis in psychological research. 
Psychol Methods, 1999; 4: 272–299. 
Filiptsova OV, Kobets MN, Kobets YN. Some aspects of 
genetics and pharmacogenetics understanding by pharmacy students in 
Ukraine. Egypt J Med Hum Genet, 2015; 16: 61-66. 
Fletcher  RH, Fletcher SW, and Wagner E.  Clinical 
epidemiology: the essentials, 3rd ed, Journal of Clinical Epidemiology. 
Williams & Wilkins, Maryland, 1996; 96: 294-296. 
Formea CM, Nicholson WT, McCullough KB, Berg KD, Berg 
ML, Cunnigham Jl, Merten JA, Ou NN, Stollings JL. Development and 
evaluation of a pharmagenomics educational program for pharmacists. Am 
J Pharm Educ, 2013; 77: 10. 
Ghasemi S, Kabir A, Ansari Jafari M, Jalali M, Amini A, 
Faghihi-Kashani AH, Alavian SM. Psychometric properties of a 
standardized questionnaire of knowledge, attitude, and practice of Iranian 
medical specialists about viral hepatitis. Hepat Mon, 2012; 12: e7650. 
Gordis  L. Epidemiology, 4th edition, Systematic biology. 2009; 
31: 254–269 
Grant JS, Davis  LL.  Selection and use of content experts for 
instrument development. Res Nurs Health, 1997; 20: 269–274. 
Hair Jr JF, Black  WC, Babin  BJ,  Anderson  RE.  Multivariate 
data analysis, 7th ed.  Upper Saddle River, NJ [etc.] : Pearson Prentice 
Hall,  New York, NY : Macmillan, 2009; 24: 899. 
Johnston JM, Leung GM, Fielding  R, Tin  KYK, Ho L-M.  The 
development and validation of a knowledge, attitude and behavior 
022                                                        Yau et al. / Journal of Applied Pharmaceutical Science 5 (11); 2015: 015-022 
 
questionnaire to assess undergraduate evidence-based practice teaching 
and learning. Med Educ, 2003; 37: 992–1000. 
Kimberlin CL, Winterstein AG. Validity and reliability of 
measurement instruments used in research. Am. J Health Syst Pharm, 
2008; 65: 2276–2284. 
Ledesma RD, Universidad  C, Mar NDe,  Valero-mora P, 
Valencia  UDe.  Determining the Number of Factors to Retain in EFA: an 
easy-to-use computer program for carrying out Parallel Analysis. Pract 
Assessment Res Eval, 2007; 12: 2–11. 
Martiniuk  ALC, Speechley  KN, Secco M,  Karen Campbell M.  
Development and psychometric properties of the Thinking about Epilepsy 
questionnaire assessing children‟s knowledge and attitudes about epilepsy. 
Epilepsy Behav, 2007; 10: 595–603. 
McEvoy MP, Williams MT, Olds TS. Development and 
psychometric testing of a trans-professional evidence-based practice 
profile questionnaire. Med Teach., 2010; 32: e373–e380. 
Montazeri A,  Goshtasebi  A, Vahdaninia  M, Gandek  B.  The 
Short Form Health Survey ( SF-36 ): Translation and validation study of 
the Iranian version. Qual Life Res., 2005; 14: 875–882. 
Rosebraugh  CJ, Tsong  Y,  Zhou  F,  Chen M,  Mackey  AC,  
Flowers C,  Toyer D,  Flockhart DA, Honig PK. Improving the quality of 
adverse drug reaction reporting by 4th-year medical students. 
Pharmacoepidemiol. Drug Saf., 2003; 12: 97–101. 
Sadee  W.  Genomics and personalized medicine. Int J Pharm, 
2011; 415: 2–4. 
Salcedo-Rocha AL,  García-de-Alba-Garcia  JE,  Velásquez-
Herrera    JG,    Barba-González     EA.    Oral   Health:   Validation   of   a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
questionnaire of self-perception and self-care habits in Diabetes Mellitus 
2, hypertensive and obese patients. The UISESS-B scale. Med. Oral Patol. 
Oral Cir. Bucal, 2011; 16: 834–839. 
Sirajudeen M, Pillai P,  Shah, U,  Mohan N. Content validity 
and inter-rater reliability of a checklist to assess the ergonomic practice of 
computer professionals. Int J Ther Rehabil Res, 2012; 1: 11-18. 
Stanek E, Sanders C, Frueh F. Physicians awareness and 
utilization of food and drug administration (FDA) - approved labelling for 
pharmacogenomic testing information. J Pers Med, 2013; 3: 111-123.    
Trochim WMK,  Donnelly  JP.  The Research Methods 
Knowledge Base.  WebRef, 2006; 1: 29:54 
Taber J, Press D. Pharmagenomic Knowledge gaps and 
educational resource needs among physicians in selected specialists. 
Pharmagenomics Pers Med, 2014; 7: 145-162. 
 
 
 
 
 
 
 
 
 
 
 
 
How to cite this article:  
 
Yau A, Husain R, Aziz AA, Johari MKBZ, Rahman AFB, Elkalmi 
RM, Jamilu Y, Haque M. Psychometric Properties of Knowledge, 
Attitude, and Practice on Pharmacogenovigilance in Drug Safety 
Questionnaire in Medicine and Pharmacy Students: based on 
Exploratory Factor Analysis. J App Pharm Sci, 2015; 5 (11): 015-
022. 
